Prestige files 8-K/A with OTC Wellness Business Q1 2026 financials; net income $12.6M

Prestige Consumer Healthcare Inc.

OTC Wellness Business net sales $51.7M for Q1 2026, up 2.4% YoY from $50.5M.
Net income $12.6M, down 14.4% from $14.8M in Q1 2025; operating income $12.6M.
Gross sales $64.1M; sales allowances, returns & discounts $12.4M (19.4% of gross).
Advertising & promotion expense $12.6M, up 24.6% YoY from $10.2M.
Filing corrects prior 8-K/A by removing inadvertently included audit report.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.